Roche is moving towards a comprehensive new hemostasis testing portfolio with a number of industry firsts and innovative applications for early disease detection and monitoring. From easy-to-use, low-volume analyzers for self- and professional monitoring, to systems meeting the high efficiency requirements of the laboratory, Roche's products provide high quality results and offer outstanding productivity while reducing complexity.
Like Roche’s current instruments, the new generation of testing solutions is driven by a commitment to deliver high-quality, cost-effective solutions capable of addressing the current and future testing needs of a wide range of customers.
The cobas t 511 and cobas t 711 coagulation analyzers are the most recent addition to Roche’s hemostasis portfolio.
These systems serve the medium to high volume coagulation laboratories. Offering workflow benefits through the connectivity to Roche’s automation line*, and featuring innovative reagent management concepts such as a reagent cassette and fully automated reagent reconstitution, the new cobas t 511 and cobas t 711 coagulation analyzers allow laboratories to do more with less.
The new coagulation analyzers, combined with the point-of-care meters, the Multiplate® analyzer and the cobas t 411, allow Roche to provide a full portfolio of solutions for primary and secondary hemostasis testing.
*only for cobas t 711